Garofalo Health Care S.p.A. (BIT:GHC)
Italy · Delayed Price · Currency is EUR 4.640
-0.030 (-0.64%)
Last updated: Apr 17, 2026, 9:04 AM CET
Garofalo Health Care Revenue
In the year 2025, Garofalo Health Care had annual revenue of 485.12M EUR with 3.71% growth. Garofalo Health Care had revenue of 121.96M in the quarter ending December 31, 2025, with 1.26% growth.
Revenue
485.12M
Revenue Growth
+3.71%
P/S Ratio
0.85
Revenue / Employee
192.05K
Employees
2,865
Market Cap
412.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 485.12M | 17.35M | 3.71% |
| Dec 31, 2024 | 467.77M | 101.63M | 27.76% |
| Dec 31, 2023 | 366.14M | 46.10M | 14.40% |
| Dec 31, 2022 | 320.04M | 37.12M | 13.12% |
| Dec 31, 2021 | 282.93M | 74.59M | 35.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.40B |
| DiaSorin | 1.20B |
| Safilo Group | 983.38M |
| EL.En. | 590.85M |
| GPI S.p.A. | 546.18M |
| Philogen | 319.73M |
| Svas Biosana | 134.95M |